Dynatronics Corporation logo
Dynatronics Corporation DYNT
report update icon

Quarterly report 2026-Q1
added 06-20-2026

Dynatronics Corporation Financial Ratios 2025-2010 | DYNT

Brief overview of Dynatronics Corporation's market valuation

The comparison uses the five latest available annual observations between 2012 and 2019.

Market valuation is represented by EV/EBITDA 16.06x (median 17.48x), P/S 0.07x (median 0.07x), P/B 0.6x (median 0.16x). The combined ratio level is close to the company's five-year norm at a -0.7% deviation. No clear premium or discount is visible.

Returns on assets and capital are represented by ROE -3.3%, ROA -70.6%, ROCE -75.2%. Negative returns point to losses or poor capital efficiency. Valuation multiples are less informative in this setting.

The time from paying for inputs to receiving cash fell from 98.6 days to 80.5 days. Cash turnover improved.

Overall assessment

Dynatronics Corporation's multiples form a balanced picture without a clear discount or premium. Future appeal depends on earnings and return trends.

Annual Financial Ratios Dynatronics Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

P/E

-0.2 -0.3 -0.5 -0.5 - -2.7 -14.0 -11.8 -4.5 -4.0 -3.5 -38.8 -134.4 -266.7 74.8 -

P/S

0.1 0.0 0.1 0.0 - 0.2 0.2 0.3 0.2 0.2 0.3 0.4 0.2 0.2 0.6 -

EPS

-1.4 -1 -1.5 -1.3 - -0.4 -0.2 -0.5 -1.4 -0.8 -2.0 -0.1 -0.0 -0.0 0.0 -

EV (Enterprise Value)

13.8 M 12.1 M 15.5 M 15.2 M 7.52 M 24.7 M 31.7 M 37.9 M 21.8 M 16.3 M 15.8 M 18.5 M 14.6 M 15 M 28.1 M -384 K

EBITDA per Share

-0.24 -0.46 -1.07 -1.13 -0.17 -0.122 0.0989 0.00922 -0.424 -0.511 -0.274 0.157 0.261 0.186 0.421 -

EV/EBITDA

-7.0 -7.6 -3.8 -3.8 -2.6 -8.5 16.1 289.1 -6.5 -5.3 -6.8 29.8 11.5 17.5 20.0 -

PEG

-0.0 -0.0 -0.0 -0.0 - 0.03 -0.23 -0.19 0.07 -0.07 0.0 0.09 1.14 2.45 -2.16 -

P/B

0.6 0.1 0.2 0.1 - 0.5 0.6 0.9 0.7 1.4 1.1 1.8 1.0 1.0 3.1 -

P/CF

6.5 -0.5 7.3 -0.4 - 3.3 127.5 36.4 -5.1 -10.3 -6.9 32.0 11.0 -21.4 18.9 -

ROE %

-334.18 -19.05 -29.50 -18.40 7.84 -17.22 -4.44 -7.50 -15.14 -34.04 -30.80 -4.51 -0.71 -0.38 4.09 -

ROA %

-70.61 -10.40 -16.54 -11.27 5.11 -9.11 -2.33 -3.81 -7.16 -12.46 -11.75 -1.90 -0.29 -0.15 1.83 -

ROCE %

-75.20 -16.05 -28.78 -21.92 -14.74 -10.00 -3.14 -4.55 -9.09 -14.95 -8.00 -2.56 1.35 0.32 7.49 -

Current Ratio

1.3 2.2 2.3 2.6 2.9 2.1 1.4 1.5 1.8 2.5 2.4 1.5 1.5 1.5 1.8 -

DSO

41.6 40.2 41.1 45.5 40.2 33.4 43.7 45.1 54.2 42.4 42.0 42.3 40.5 42.4 41.2 -

DIO

91.1 95.3 116.7 100.8 77.9 79.8 97.0 91.2 111.3 90.9 98.7 129.0 126.8 112.9 102.0 -

DPO

52.2 53.1 64.1 53.7 19.5 28.7 33.6 28.3 35.1 34.8 45.9 51.0 54.4 44.7 38.4 -

Operating Cycle

132.7 135.5 157.8 146.3 118.1 113.2 140.7 136.3 165.6 133.4 140.7 171.3 167.2 155.3 143.2 -

Cash Conversion Cycle

80.5 82.4 93.7 92.6 98.6 84.5 107.2 107.9 130.5 98.5 94.9 120.3 112.8 110.6 104.7 -

All numbers in USD currency

Quarterly Financial Ratios Dynatronics Corporation

2026-Q1 2025-Q3 2025-Q2 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.03 -0.13 - -0.13 -0.09 -0.13 -0.09 -0.27 -0.12 - -0.36 -0.27 -0.18 - -0.46 -0.09 0.02 -0.08 - -0.06 -0.04 -0.06 -0.04 -0.05 -0.01 -0.05 -0.09 -0.08 0.02 -0.08 0.02 -0.23 - -0.23 -0.28 -0.19 -0.13 -0.19 -0.13 -0.08 -0.1 -0.08 -0.1 -0.05 0.02 -0.05 0.02 0.02 -0.04 0.02 -0.04 0.06 -0.02 0.06 - 0.02 -0.01 - -0.01

EBITDA per Share

- -0.07 - - -0.02 -0.06 -0.02 - -0.02 - - -0.21 -0.08 -0.25 -0.4 -0.08 -0.01 -0.08 -0.04 -0.04 -0.01 -0.01 -0.01 - 0.06 0.05 0.06 -0.01 0.03 0.02 0.02 0.02 0.07 0.05 0.04 -0.03 -0.11 -0.07 -0.11 -0.02 -0.06 -0.06 -0.06 -0.06 - -0.13 - 0.05 -0.09 -0.04 -0.09 0.1 -0.05 0.19 0.01 0.04 - 0.02 -

ROE %

-289.42 -285.48 -283.12 -17.22 -17.78 -17.12 -25.29 -29.12 -26.72 -27.10 -20.18 -20.03 -21.76 -17.53 -14.09 -7.23 -4.94 -8.78 -9.81 -13.25 -11.85 -10.18 -7.54 -4.94 -5.81 -4.88 -5.75 -4.84 -7.50 -8.01 -10.67 -11.18 -14.47 -21.54 -17.57 -22.77 -15.58 -11.14 -11.14 -8.51 -8.98 -5.76 -6.28 -3.11 -0.15 -2.59 0.34 -2.07 -0.59 0.36 1.90 2.82 1.35 1.08 -0.47 -0.69 -1.09 0.70 -1.03

ROA %

-65.36 -65.48 -64.22 -8.94 -9.38 -9.01 -13.92 -16.19 -15.14 -15.49 -11.99 -12.18 -13.61 -10.94 -8.98 -4.76 -2.72 -4.97 -4.93 -6.75 -6.03 -5.16 -3.88 -2.53 -3.13 -2.66 -3.06 -2.58 -3.80 -4.07 -7.59 -7.85 -8.39 -10.87 -6.45 -8.37 -5.68 -4.29 -4.32 -3.40 -3.41 -2.13 -2.41 -1.18 -0.13 -1.08 0.15 -0.85 -0.23 0.16 0.79 1.17 0.56 0.45 -0.16 -0.29 -0.45 0.31 -0.46

ROCE %

-17.68 -19.91 -12.06 -13.88 -14.56 -14.19 -15.43 -17.52 -13.95 -12.50 -18.37 -18.20 -19.97 -19.39 -20.70 -17.18 -14.65 -14.81 -10.78 -9.87 -6.88 -3.97 -0.97 1.88 1.60 0.74 0.46 -0.40 0.50 2.36 3.26 5.13 3.27 -3.47 -5.49 -12.04 -11.30 -8.21 -7.28 -4.34 -6.22 -3.04 -4.92 -1.76 2.77 -0.71 3.78 0.31 2.36 3.98 6.13 7.72 5.47 4.92 2.50 1.99 -0.78 1.72 -0.74

Current Ratio

1.3 2.0 1.3 2.0 2.2 2.0 2.2 2.1 2.2 2.3 2.4 2.4 2.5 2.6 2.6 2.9 3.0 2.9 2.3 2.0 2.1 2.1 2.1 2.0 2.0 2.1 2.1 2.2 2.1 2.0 2.0 2.0 1.7 1.9 1.9 1.6 1.5 1.6 1.6 1.7 1.7 1.6 1.6 1.5 1.5 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.8 1.8

DSO

36.1 41.8 - 36.8 35.3 36.8 40.8 44.8 38.9 - 47.4 45.1 41.4 21.0 47.4 50.6 43.5 22.9 43.3 40.7 39.5 37.3 44.5 42.8 41.2 45.0 40.2 45.7 43.7 46.2 41.7 33.4 39.7 15.6 51.2 35.8 39.0 36.9 36.6 37.8 40.2 40.9 38.9 38.2 40.0 39.5 39.0 40.0 42.0 41.5 45.3 42.6 46.7 41.8 46.6 41.6 43.0 20.6 -

DIO

88.7 95.1 - 96.9 97.5 96.9 99.2 97.9 92.2 - 132.8 132.1 130.0 66.6 119.4 89.2 72.5 35.7 72.7 65.1 80.6 88.5 109.5 96.8 92.0 99.1 89.2 88.9 85.2 93.2 89.5 69.5 78.5 54.8 70.0 87.9 87.4 80.8 89.0 104.0 101.7 103.1 106.5 113.2 119.5 116.1 124.9 130.9 129.1 130.8 127.5 113.5 123.7 113.6 121.1 104.8 104.5 101.8 -

DPO

59.2 64.1 - 50.0 50.3 50.0 54.5 56.5 54.4 - 79.3 75.7 71.1 36.2 64.9 25.3 19.8 10.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 20.4 45.0 39.6 39.1 38.3 -

Operating Cycle

- 121.2 - 133.6 128.8 - - 142.7 131.2 - 180.2 177.2 171.5 87.6 166.8 139.8 116.0 58.6 116.0 105.8 120.1 125.9 154.0 139.6 133.2 144.1 129.3 134.6 128.9 139.3 131.2 102.9 118.2 70.4 121.3 123.8 126.4 117.8 125.5 141.8 141.9 144.0 145.3 151.4 159.5 155.7 163.9 170.9 171.2 172.3 172.8 156.1 170.4 155.4 167.7 146.4 147.5 122.4 -

Cash Conversion Cycle

- 64.5 - 83.6 84.6 - - 86.2 76.8 - 100.9 101.5 100.4 51.4 102.0 114.5 96.2 48.6 116.0 105.8 120.1 125.9 154.0 139.6 133.2 144.1 129.3 134.6 128.9 139.3 131.2 102.9 118.2 70.4 121.3 123.8 126.4 117.8 125.5 141.8 141.9 144.0 145.3 151.4 159.5 155.7 163.9 170.9 171.2 172.3 172.8 156.1 170.4 135.0 122.7 106.8 108.4 84.0 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Dynatronics Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
- 0.28 % $ 270 M usaUSA
AxoGen AxoGen
AXGN
$ 48.28 2.51 % $ 2.22 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 58.5 0.13 % $ 8.88 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 74.29 2.75 % $ 2.2 B costa-ricaCosta-rica
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 108.33 0.19 % $ 189 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 1.82 6.04 % $ 1.23 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 6.49 1.09 % $ 877 M usaUSA
Align Technology Align Technology
ALGN
$ 158.64 0.03 % $ 11.5 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.05 0.32 % $ 125 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.27 0.3 % $ 33.1 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 9.45 1.29 % $ 1.42 B usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 7.36 0.96 % $ 1.82 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 386.11 0.05 % $ 10.5 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 47.8 1.83 % $ 70.8 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.47 0.71 % $ 618 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 13.96 0.67 % $ 395 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 49.32 0.02 % $ 1.53 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.35 0.03 % $ 21.8 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 16.48 1.1 % $ 590 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA